NICE draft RA recommendations leave "little hope for patients"
This article was originally published in Scrip
Executive Summary
NICE, the health technology appraisal body for England and Wales, today published draft recommendations saying that rheumatoid arthritis (RA) patients should only be prescribed a second TNF-inhibitor as part of clinical research.